Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

T. Rowe Price US Large-Cap Core Eq Comp

Vanguard Value Index Inv

American Century Mid Cap Value Inv

American Century U.S. Mid Cap Value

Invesco S&P 500® Equal Weight ETF

GMO Quality Composite

GMO Quality IV

The Health Care Select Sector SPDR® ETF

Vanguard Mid-Cap Value ETF

JPM US Mid Cap Value-MA

Victory Sycamore Established Value R

Vanguard Mid Cap Index Institutional

Vanguard Windsor Investor Shares

T. Rowe Price US Large-Cap Core

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

T. Rowe Price U.S. Large-Cap Core Tr-B

Vanguard Group Inc

BlackRock Inc

Dimensional Fund Advisors, Inc.

Morgan Stanley - Brokerage Accounts

Amvescap Plc.

JPMorgan Chase & Co

Wells Fargo & Co

Fiduciary Management, Inc. of Milwaukee

Goldman Sachs Group Inc

NORGES BANK

FMR Inc

Northern Trust Corp

State Street Corp

T. Rowe Price Associates, Inc.

Victory Capital Management Inc.

Geode Capital Management, LLC

Davis Selected Advisers

Wellington Management Company LLP

American Century Companies Inc

Grantham, Mayo, Van Otterloo & Co., LLC

Quest Diagnostics Incorporated

Mr. James E. Davis

Chairman, CEO & President

Mr. Sam A. Samad

Executive VP & CFO

Mr. Michael E. Prevoznik J.D.

Senior VP & General Counsel

Ms. Catherine T. Doherty

Executive Vice President of Regional Businesses

Mr. Karthik  Kuppusamy Ph.D.

Senior Vice President of Clinical Solutions

Mr. Michael J. Deppe

Senior VP, Corporate Controller & Chief Accounting Officer

Mr. Murali  Balakumar

Senior VP, Chief Information & Digital Officer

Mr. Shawn C. Bevec

Vice President of Investor Relations

Ms. Kristin Lee Wallace Esq.

Senior VP & Chief Compliance Officer

Mr. Gary D. Samuels

Senior VP & Chief Communications Officer

DGX's next earnings is on January 30, 2025 (Before Market Open)

DGX's latest dividend is 0.75 USD on October 4, 2024

Quest Diagnostics Incorporated (DGX) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Quest Diagnostics Incorporated (DGX) Earnings Report Date and History | NYSE

DGX's next earnings is on January 30, 2025 (Before Market Open)

When is the earnings report for DGX?

DGX Earnings History

DGX's latest dividend is 0.75 USD on October 4, 2024

DGX Stock Discussion Forum and Message Board

News for NYSE: DGX